To assess the dynamic regulation of LAPTM4B during the acquisition of drug resistance, we collected matched tumor tissues from six patients with histologically confirmed lung adenocarcinoma, all carrying EGFR 19Del mutations (Supplementary Table S2). Here, LAPTM4B is linked to neoplasm.